title: [Endocrine therapy for localized or locally advanced prostate cancer].
abstract: The place of endocrine therapy, either alone or in combination with radiotherapy and surgery, remains highly controversial in the treatment of non-metastatic prostate cancer. The authors review the results of isolated endocrine therapy or associated with local therapy. At the present time, there are few arguments in favour of the use of endocrine therapy in the following situations: isolated treatment of localized or locally advanced cancer prior to radical prostatectomy, after radical prostatectomy. Current data suggest a benefit of endocrine therapy in combination with radiotherapy in patients with high-grade localized or locally advanced cancer.
authors.affiliation: Service d'Urologie, Hopital Ambroise Paré, Boulogne, France. eric.fontaine@apr-hop-paris.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Fontaine
authors.forename: Alain
authors.initials: A
authors.lastname: Ruffion
authors.forename: Frédéric
authors.initials: F
authors.lastname: Staerman
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery
chemical_list: D000726:Androgen Antagonists
vernacular_title: Traitement hormonal du cancer de la prostate localisé ou localement avancé.